Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
5,140.00
+80.00 (1.58%)
At close: Aug 3, 2026
-23.05% (1Y)
| Market Cap | 57.56B -24.3% |
| Revenue (ttm) | 82.18B -4.4% |
| Net Income | 6.95B -45.1% |
| EPS | 601.36 -45.1% |
| Shares Out | 11.38M |
| PE Ratio | 8.41 |
| Forward PE | n/a |
| Dividend | 190.00 (3.75%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 12,076 |
| Open | 5,030.00 |
| Previous Close | 5,060.00 |
| Day's Range | 5,030.00 - 5,210.00 |
| 52-Week Range | 4,820.00 - 6,820.00 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |